Sanofi
Sanofi (SNY) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · SNY · as of Sep 30, 2024
Ownership Breakdown
774
Institutional Holders
▲ 27 vs Q2
$16.26B
Total Inst. Value
▲ $3.01B vs Q2
2.41B
Shares Outstanding
freeFloat 90.30%
281.87M
13F Shares Held
▲ 9.92M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
SNY largest shareholders · institutional ownership
Q3 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
DODGE & COX pharmaceutical preparations | 76.30M | 6.09% | 6.09% | $4.40T | Nov 13, 2024 | ▼ 812.5K |
MORGAN STANLEY pharmaceutical preparations | 17.78M | 1.41% | 1.41% | $1.02T | May 14, 2025 | ▲ 3.04M |
FISHER ASSET MANAGEMENT, LLC pharmaceutical preparations | 13.36M | 1.07% | 1.07% | $769.89B | Nov 12, 2024 | ▼ 239.4K |
INVESCO LTD. pharmaceutical preparations | 11.65M | 92.98% | 92.98% | $671.42B | Nov 12, 2024 | ▲ 1.14M |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 11.58M | 92.38% | 92.38% | $667.10B | Nov 14, 2024 | ▲ 367.4K |
BLACKROCK, INC. pharmaceutical preparations | 10.34M | 82.51% | 82.51% | $595.80B | Nov 13, 2024 | NEW |
BANK OF NEW YORK MELLON CORP pharmaceutical preparations | 9.31M | 74.32% | 74.32% | $536.68B | Nov 12, 2024 | ▲ 717.8K |
FMR LLC pharmaceutical preparations | 8.62M | 68.78% | 68.78% | $496.63B | Nov 13, 2024 | ▼ 6.60M |
BARROW HANLEY MEWHINNEY & STRAUSS LLC pharmaceutical preparations | 7.84M | 62.55% | 62.55% | $451.69B | Nov 13, 2024 | ▲ 1.89M |
PRICE T ROWE ASSOCIATES INC /MD/ pharmaceutical preparations | 5.75M | 45.91% | 45.91% | $331.51B | Nov 14, 2024 | ▲ 3.89M |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2024 vs prior quarter
Q3 2024
29
Increased
+18.77M shares2
New Positions
first time holders19
Decreased
−9.98M shares0
Sold Out
fully exitedNet shares change (top 50)
+8.79M
+18.77M / −9.98M
Net new holders
+12
2 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
SNY insider trading · insider activity
Source: SEC Form 4
Recent Insider Transactions
Showing 10 most recent · Common Stock only
No recent insider transactions reported.
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Sanofi (SNY) is primarily owned by institutional investors, who hold approximately 11.7% of total shares outstanding. Company insiders own approximately 9.70%, while retail and public investors account for the remaining 78.60%.
The largest institutional shareholder of Sanofi is DODGE & COX, holding approximately 76.30 million shares — equal to 6.09% of outstanding shares — as of September 30, 2024.
A total of 774 institutional investors currently hold SNY stock, with a combined institutional value of approximately $16.26 billion as of the most recent 13F filing period.
Frequently asked questions
SNY ownershipSanofi (SNY) is primarily owned by institutional investors, who hold approximately 11.7% of shares. The largest shareholder is DODGE & COX with a 6.09% stake. Company insiders hold 9.70%. Data sourced from SEC Form 13F as of September 30, 2024.